TECX Tectonic Therapeutic, Inc.
$20.56▲ +1.08%
Healthcare
Other
After hours
$20.28▼ -1.37%
Oct 28, 4:46 PM ET
Volume 215.9K
Avg Volume (10D) 182.8K
Key Metrics & Fundamentals
Market Cap
$401.93M
P/E Ratio
–
Div Yield
0.00%
52W Range
15.52 - 39.53
% vs 50 MA
-22.89%
% vs 200 MA
-26.78%
RSI-14
34.4
MACD Histogram
+0.1700
Beta (1Y vs SPY)
0.83
Free Cash Flow
-$21.53M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$21.92M
COGS
–
Operating Exp
$24.22M
Operating Income
-$24.22M
EBIT
-$24.22M
Pretax Income
-$22.21M
Net Income
-$22.29M
EPS (Diluted)
-1.18
Price & Volume History
Loading chart…
Recent News
Tectonic Therapeutic Says TX2100 Phase 1a Trial Met Primary Objectives
MT Newswires · Sep 29, 2026 10:29 AM ET
Tectonic Therapeutic Announces Favorable Phase 1 Safety, Tolerability and PK Results for TX2100, a Novel Approach for the Treatment of Hereditary Hemorrhagic Telangiectasia (HHT)
GlobeNewswire · Sep 29, 2026 8:00 AM ET
Tectonic Therapeutic (TECX) Clears Two Trial Hurdles With Cash To Spare
Insider Monkey · Sep 10, 2026 12:55 AM ET
Tectonic Therapeutic to Participate in the Morgan Stanley Global Healthcare Conference
GlobeNewswire · Sep 3, 2026 8:00 AM ET
Tectonic Therapeutic Announces Second Quarter 2026 Financial Results and Recent Business Highlights
GlobeNewswire · Aug 6, 2026 4:01 PM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See TECX's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.